January 20, 2022
MycoWorks’ $125 million in Series C Funding will be used to launch the first full-scale Fine Mycelium production plant to meet the growing demand for the company’s materials, including its flagship product, Reishi, which is a leather-like product made from mushrooms. | Photo courtesy of MycoWorks
Stories this photo appears in:
San Francisco–based biomaterials company MycoWorks announced it has secured $125 million during its latest funding round.